General Biologicals Corporation (TPEX:4117)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.90
-0.30 (-2.46%)
Jan 22, 2026, 2:20 PM CST

General Biologicals Company Description

General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.

It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services.

The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma.

Additionally, it offers a range of oral care products under the oh care brand. Further, the company serves its diagnostic solutions through clinics and laboratories.

General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.

General Biologicals Corporation
CountryTaiwan
Founded1984
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees81
CEOT.C. Lin

Contact Details

Address:
No. 6, Innovation First Road
Hsinchu City, 300092
Taiwan
Phone886 3 577 9221
Websitegbc.com.tw

Stock Details

Ticker Symbol4117
ExchangeTaipei Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyTWD
ISIN NumberTW0004117007
SIC Code2835

Key Executives

NamePosition
Frank Lin M.B.A.President and Director
Dr. C.M. LingFounder
Ming Shan LiuDeputy General Manager of Sales Marketing and Director